Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Both mouse and rat models are effective for testing alopecia areata treatments.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Psoriasis can cause temporary or permanent hair loss.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Four genes are linked to alopecia areata, with two increasing risk and two offering protection.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Nanostructured lipid carriers can improve alopecia treatment by enhancing drug delivery and promoting hair growth.

Rare genetic variants in 125 genes are linked to male-pattern hair loss.

Ceramide Synthase 4 is crucial for healthy skin barrier function.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Certain gut bacteria may protect against or increase the risk of hair loss.

Genetic risk for hair loss can increase depression risk, but depression doesn't increase hair loss risk.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.